Elanco Animal Health Inc Quarterly Deferred Income Tax Expense (Benefit) in USD from Q1 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Elanco Animal Health Inc annual/quarterly Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2018 to Q1 2023.
  • Elanco Animal Health Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $2M.
  • Elanco Animal Health Inc annual Deferred Income Tax Expense (Benefit) for 2023 was -$80M, a 40.4% decline from 2022.
  • Elanco Animal Health Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$57M, a 61.5% increase from 2021.
  • Elanco Animal Health Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$148M, a 29.8% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $2M +$9M Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q1 2022 -$7M +$21M +75% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 -$28M -$3M -12% Jan 1, 2021 Mar 31, 2021 10-K 2023-03-01
Q1 2020 -$25M -$41.3M -253% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $16.3M +$18.7M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q1 2018 -$2.4M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.